hTERT peptide-based vaccine- InvectysAlternative Names: hTERT prptide vaccine- Invectys; Human telomerase reverse transcriptase peptide-based vaccine - Invectys; UCPVax
Latest Information Update: 04 Jul 2016
At a glance
- Originator Invectys
- Developer Invectys; Regional and University Hospital of Besancon
- Class Cancer vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Non-small cell lung cancer
Most Recent Events
- 01 May 2016 Phase-I/II clinical trials in Non-small cell lung cancer (Metastatic disease, Late-stage disease, Second-line therapy or greater) in France (SC) (NCT02818426)